ADL
VRTX icon

Asset Dedication LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Asset Dedication LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118K Hold
237
– – 0.01% 378
2026
Q1 		$106K Sell
237
-57
-19% -$26.6K 0.01% 384
2025
Q4 		$133K Hold
294
– – 0.01% 364
2025
Q3 		$115K Buy
294
+19
+7% +$7.94K 0.01% 400
2025
Q2 		$122K Buy
275
+71
+35% +$32.7K 0.01% 387
2025
Q1 		$98.9K Sell
204
-10
-5% -$4.66K 0.01% 371
2024
Q4 		$86.2K Buy
214
+12
+6% +$5.56K 0.01% 396
2024
Q3 		$93.9K Hold
202
– – 0.01% 420
2024
Q2 		$94.7K Buy
202
+100
+98% +$43.4K 0.01% 410
2024
Q1 		$42K Hold
102
– – ﹤0.01% 472
2023
Q4 		$42K Hold
102
– – ﹤0.01% 462
2023
Q3 		$35K Buy
102
+58
+132% +$20.3K ﹤0.01% 478
2023
Q2 		$15K Hold
44
– – ﹤0.01% 614
2023
Q1 		$14K Buy
+44
New +$13.2K ﹤0.01% 625
2020
Q4 		– Sell
-37
Closed -$10K – 822
2020
Q3 		$10K Buy
+37
New +$10.2K ﹤0.01% 537
2016
Q4 		– Sell
-42
Closed -$4K – 425
2016
Q3 		$4K Buy
+42
New +$3.97K ﹤0.01% 360
2016
Q1 		– Sell
-42
Closed -$5K – 650
2015
Q4 		$5K Buy
+42
New +$5.07K ﹤0.01% 469

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Asset Dedication LLC's VRTX Position: Q2 2026 in Review

Asset Dedication LLC held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 237 shares worth $118K. The position accounts for 0.01% of the portfolio, ranked #378.

Asset Dedication LLC first reported a position in VRTX in Q4 2015 and has held it in 17 quarters since. The position peaked at $133K in Q4 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Asset Dedication LLC held 237 shares of Vertex Pharmaceuticals worth $118K as of Q2 2026.
  • Asset Dedication LLC left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.01% of Asset Dedication LLC's portfolio in Q2 2026, its #378 holding.
  • Asset Dedication LLC first reported a position in Vertex Pharmaceuticals in Q4 2015 and has held it in 17 quarters since.
  • Asset Dedication LLC's Vertex Pharmaceuticals position peaked at $133K in Q4 2025.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.